Pediatric blood & cancer 2023 Feb 11
Sodium thiosulfate as cisplatin otoprotectant in children: The challenge of when to use it.
Related Questions
STS was approved in 2022 in the US to reduce risk of ototoxicity associated with cisplatin in pediatric patients 1 month of age and older with localiz...
New answer by at Children's Hospital Los Angeles (February 19, 2025)
Sodium thiosulfate (STS) is approved in the US (FDA) and Europe (EMA) for the prevention of cisplatin-induced hearing loss (CIHL) in patients 1 month and older treated with ci...